What happens when you take matcha with warfarin?
Matcha is finely powdered whole green tea leaf. Unlike brewed sencha or bancha, where most of the leaf is discarded after steeping, matcha is whisked into hot water and the entire leaf is consumed. That means each gram of matcha delivers the full vitamin K content of the original leaf, not just the small fraction that leaches into a cup of brewed tea. A typical 1-2 gram serving of matcha can contain meaningfully more vitamin K than a brewed cup of green tea, and a daily matcha latte made with 2-3 grams of powder amplifies the effect further.
Warfarin (Coumadin, Jantoven) works by inhibiting vitamin K epoxide reductase in the liver, depleting active vitamin K and reducing synthesis of clotting factors II, VII, IX, and X. When dietary vitamin K goes up, the liver makes more clotting factors, the international normalised ratio (INR) falls, and the anticoagulant effect of warfarin weakens. The published case report on green tea and warfarin describes a patient whose INR fell from his target range to 1.37 after he began drinking a gallon of green tea a day, and recovered to 2.55 after stopping. Matcha can reproduce a similar effect at much smaller leaf weights because the whole leaf is ingested.
Why is this important?
Warfarin has a narrow therapeutic window, typically INR 2.0-3.0 (or 2.5-3.5 for mechanical heart valves). When INR drops below the target range, the risk of stroke, deep vein thrombosis, pulmonary embolism, and valve thrombosis rises sharply. When INR overshoots, the risk of major bleeding - including gastrointestinal and intracranial haemorrhage - rises.
Because warfarin is dosed against an INR that depends on dietary vitamin K intake, the central principle of warfarin diet management is consistency. Patients are taught to eat roughly the same amount of leafy greens, broccoli, and other vitamin-K-rich foods each week rather than to avoid them. The same applies to matcha. A patient who starts a daily matcha latte habit after months of stable INRs can see their INR drift below target, and a patient who suddenly stops a daily matcha habit can see INR rise above target. Both situations are clinically risky and often missed because patients do not think of matcha as a medication-relevant change.
The risk is greater with matcha than with brewed green tea because of the whole-leaf delivery, and greater still with high-grade ceremonial matcha used at higher doses or with matcha-based supplements and ready-to-drink matcha lattes.
What should you do?
If you are on warfarin, the safest approach is to avoid daily matcha. If matcha is important to you, limit it to a small, consistent amount (for example, half a teaspoon, around 1 gram, in a single morning drink) every day rather than several large servings on some days and none on others. Tell your anticoagulation clinic about your intake and ask for an INR check 1-2 weeks after starting or stopping a matcha habit so any drift can be picked up early.
Avoid matcha-based weight-loss regimens and high-dose matcha shots, which can deliver several grams of powdered leaf per day. Also avoid green tea extract or matcha extract capsules, which provide concentrated catechins and may contain residual vitamin K. If you are switching from warfarin to a direct oral anticoagulant (DOAC) such as apixaban, rivaroxaban, edoxaban, or dabigatran, this particular interaction no longer applies because DOACs do not depend on vitamin K.
Patients sometimes ask whether matcha taken at a different time of day from warfarin avoids the problem. It does not. The interaction is pharmacodynamic - warfarin and dietary vitamin K both act on the liver's clotting-factor synthesis pathway over days, not minutes - so timing within a day does not help. Total daily intake and consistency are what matter.
Which specific products are affected?
The interaction is with warfarin (Coumadin, Jantoven) and other coumarin anticoagulants such as acenocoumarol and phenprocoumon. Direct oral anticoagulants (apixaban, rivaroxaban, edoxaban, dabigatran) are not affected.
All forms of matcha are implicated: ceremonial-grade matcha, culinary-grade matcha, matcha lattes (cafe-made and ready-to-drink), matcha smoothies, matcha-flavoured energy bars and protein powders, matcha ice cream, and matcha-containing weight-loss supplements. Concentrated green tea extract and matcha extract capsules may also contribute residual vitamin K and should be avoided. Standard brewed green tea is lower-risk per cup but still counts towards the daily vitamin K total.
The bottom line
Matcha is whole powdered green tea leaf and delivers significantly more vitamin K per serving than brewed green tea. In a warfarin patient, daily or fluctuating matcha consumption can lower INR and weaken anticoagulation, with the published green tea case report providing the proof of concept. Avoid daily matcha if possible, keep any intake small and consistent, skip matcha-based supplements and weight-loss programs, and inform your anticoagulation clinic about any changes. If you are on a DOAC instead, this interaction does not apply.